Your browser is no longer supported. Please, upgrade your browser.
GEO [NYSE]
The GEO Group, Inc.
Index- P/E7.77 EPS (ttm)0.94 Insider Own3.38% Shs Outstand119.85M Perf Week-14.69%
Market Cap897.65M Forward P/E7.04 EPS next Y1.04 Insider Trans-0.08% Shs Float117.22M Perf Month-8.96%
Income113.00M PEG0.52 EPS next Q0.19 Inst Own72.10% Short Float20.52% Perf Quarter-22.54%
Sales2.35B P/S0.38 EPS this Y-32.50% Inst Trans8.29% Short Ratio5.62 Perf Half Y-34.47%
Book/sh7.62 P/B0.96 EPS next Y13.04% ROA2.60% Target Price- Perf Year-53.20%
Cash/sh2.31 P/C3.17 EPS next 5Y15.00% ROE12.10% 52W Range6.70 - 17.22 Perf YTD-17.38%
Dividend1.00 P/FCF7.69 EPS past 5Y-5.60% ROI5.40% 52W High-54.12% Beta0.84
Dividend %13.66% Quick Ratio1.70 Sales past 5Y5.00% Gross Margin24.30% 52W Low17.91% ATR0.49
Employees20000 Current Ratio1.70 Sales Q/Q-7.00% Oper. Margin9.70% RSI (14)44.09 Volatility5.56% 6.93%
OptionableYes Debt/Eq3.19 EPS Q/Q-68.90% Profit Margin4.80% Rel Volume3.74 Prev Close7.32
ShortableYes LT Debt/Eq3.16 EarningsFeb 16 BMO Payout188.50% Avg Volume4.28M Price7.90
Recom2.00 SMA20-5.30% SMA50-8.91% SMA200-23.64% Volume4,822,193 Change7.92%
Jun-29-20Initiated Noble Capital Markets Outperform $15
Feb-15-19Downgrade JP Morgan Overweight → Neutral $26
Jul-14-17Initiated JP Morgan Overweight $35
Mar-08-17Reiterated Canaccord Genuity Buy $52 → $50
Feb-24-17Reiterated Canaccord Genuity Buy $43 → $52
Dec-12-16Reiterated Canaccord Genuity Buy $35 → $38
Nov-11-16Reiterated Canaccord Genuity Buy $29 → $35
Sep-01-16Reiterated SunTrust Buy $38 → $32
Aug-24-16Reiterated Canaccord Genuity Buy $38 → $28
Aug-03-16Reiterated Canaccord Genuity Buy $37 → $38
Jul-14-15Initiated Canaccord Genuity Buy $43
Feb-19-15Reiterated MLV & Co Buy $48 → $50
Aug-07-14Reiterated CRT Capital Buy $41 → $43
Jan-29-14Reiterated Barclays Overweight $45 → $39
Jan-24-14Initiated CRT Capital Buy $41
Apr-10-13Upgrade Barclays Equal Weight → Overweight $36 → $45
Jan-08-13Reiterated Barclays Equal Weight $30 → $34
May-08-12Reiterated Barclays Equal Weight $23 → $25
Dec-13-11Downgrade Barclays Capital Overweight → Equal Weight $25 → $22
Aug-19-11Reiterated Barclays Capital Overweight $30 → $28
Feb-25-21 06:55AM  
Feb-22-21 12:21PM  
Feb-19-21 06:55AM  
Feb-18-21 10:35AM  
Feb-17-21 04:15PM  
Feb-16-21 05:00PM  
08:45AM  
06:55AM  
Feb-15-21 05:04PM  
Feb-10-21 01:00PM  
Feb-09-21 04:22PM  
Feb-03-21 11:00AM  
Jan-29-21 01:19AM  
Jan-28-21 12:04PM  
Jan-27-21 03:37PM  
02:57PM  
02:04PM  
Jan-26-21 03:11PM  
Jan-22-21 06:55AM  
Jan-21-21 10:15AM  
Jan-20-21 06:55AM  
Jan-15-21 06:55AM  
Dec-15-20 01:13AM  
Dec-11-20 09:09PM  
Nov-23-20 06:55AM  
Nov-10-20 01:23PM  
Nov-09-20 09:05AM  
07:02AM  
Nov-06-20 11:40AM  
06:57AM  
Nov-05-20 06:40PM  
10:48AM  
08:00AM  
Nov-04-20 01:17PM  
Nov-02-20 12:04PM  
07:05AM  
Oct-30-20 07:31PM  
Oct-29-20 09:45AM  
08:35AM  
06:55AM  
Oct-26-20 07:21AM  
Oct-22-20 09:05AM  
Oct-13-20 04:15PM  
Oct-09-20 01:35PM  
11:28AM  
Oct-08-20 12:10PM  
08:20AM  
Oct-07-20 11:40AM  
Oct-06-20 06:45AM  
Oct-02-20 10:02AM  
Sep-28-20 04:52PM  
Sep-08-20 01:45PM  
12:42PM  
11:30AM  
11:15AM  
10:00AM  
09:47AM  
Sep-07-20 04:30PM  
11:02AM  
11:00AM  
08:30AM  
Sep-05-20 03:45PM  
Sep-04-20 08:05PM  
07:30PM  
12:30PM  
11:30AM  
11:10AM  
11:00AM  
10:50AM  
10:09AM  
Sep-03-20 01:15PM  
11:45AM  
11:20AM  
11:00AM  
10:09AM  
10:01AM  
09:31AM  
08:00AM  
Sep-02-20 06:45PM  
05:40PM  
05:00PM  
04:50PM  
03:34PM  
01:38PM  
12:32PM  
11:00AM  
10:30AM  
09:33AM  
06:30AM  
Sep-01-20 10:55PM  
08:26PM  
07:00PM  
05:25PM  
04:10PM  
03:40PM  
03:33PM  
02:15PM  
01:01PM  
11:40AM  
11:00AM  
The GEO Group (NYSE: GEO) is the first fully integrated equity real estate investment trust specializing in the design, financing, development, and operation of secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom. GEO is a leading provider of enhanced in-custody rehabilitation, post-release support, electronic monitoring, and community-based programs. GEO's worldwide operations include the ownership and/or management of 123 facilities totaling approximately 93,000 beds, including projects under development, with a workforce of approximately 23,000 professionals.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FOREMAN ANNE NDirectorAug 25Sale11.123,50038,92015,000Aug 27 04:56 PM
GLANTON RICHARD HDirectorAug 10Sale10.882,83830,8632,177Aug 12 04:27 PM
GLANTON RICHARD HDirectorJun 08Sale14.652,10030,7675,015Jun 10 07:46 PM
ZOLEY GEORGE CChairman & CEOMay 14Buy10.374,85050,27952,450May 18 06:11 PM
ZOLEY GEORGE CChairman & CEOMay 07Buy11.43100,0001,142,99550,000May 08 07:25 PM
ZOLEY GEORGE CChairman & CEOMay 06Buy11.24150,0001,685,2802,750,000May 08 07:25 PM
EVANS BRIANSVP, Chief Financial OfficerMar 12Buy11.215,00056,040116,793Mar 16 08:06 PM
ZOLEY GEORGE CChairman & CEOMar 12Buy11.65100,0001,164,6802,600,000Mar 16 04:25 PM
Venturella David JSVP-Business DevelopmentMar 10Buy14.856,57497,60960,606Mar 12 08:08 PM
ZOLEY GEORGE CChairman & CEOFeb 26Buy16.17250,0004,043,6002,365,060Feb 28 04:30 PM